Dr. Mayank Dalakoti is a preventive cardiologist in Singapore, currently based in Cambridge, United Kingdom. He graduated with a Bachelor’s in Medicine and Surgery (MBBS) from the National University of Singapore, followed by a Master’s in Medicine (MMed) and a Membership to the Royal College of Physicians (MRCP), United Kingdom.

His life’s mission is to arrest the epidemic of cardiometabolic disease. He completed his clinical training in cardiology in Singapore with a focus on prevention. Currently, his work in preventive cardiology includes research into predictive biomarkers of preclinical cardiometabolic disease, aiming to identify early therapeutic interventions.

Dr. Mayank also collaborates with community providers to develop comprehensive yet personalized healthcare delivery for individuals and communities, leveraging artificial intelligence and wearable technologies. He is currently pursuing academic training in population health and research at Cambridge University.

With a strong conviction that education is key, Dr. Mayank believes that only by educating individuals and groups on the best practices for heart health can we influence the trajectory of cardiometabolic disease.